Structure–Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In VivoActivity

MLA

Albanese, Valentina, et al. “Structure–Activity Relationship Studies on Oxazolo[3,4-a]Pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In VivoActivity.” Journal of Medicinal Chemistry, vol. 64, no. 7, Apr. 2021, pp. 4089–108. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.0c02223.

APA

Albanese, V., Ruzza, C., Marzola, E., Bernardi, T., Fabbri, M., Fantinati, A., Trapella, C., Reinscheid, R. K., Ferrari, F., Sturaro, C., Calò, G., Amendola, G., Cosconati, S., Pacifico, S., Guerrini, R., & Preti, D. (2021). Structure–Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In VivoActivity. Journal of Medicinal Chemistry, 64(7), 4089–4108. https://doi.org/10.1021/acs.jmedchem.0c02223

Chicago

Albanese, Valentina, Chiara Ruzza, Erika Marzola, Tatiana Bernardi, Martina Fabbri, Anna Fantinati, Claudio Trapella, et al. 2021. “Structure–Activity Relationship Studies on Oxazolo[3,4-a]Pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In VivoActivity.” Journal of Medicinal Chemistry 64 (7): 4089–4108. doi:10.1021/acs.jmedchem.0c02223.